We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

By LabMedica International staff writers
Posted on 01 Oct 2024
Print article
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide quicker results but often lack the sensitivity and accuracy of PCR. Now, a new method that combines confocal fluorescence microscopy with microfluidic laminar flow marks a significant advancement in virus detection. Unlike traditional PCR, this innovative approach can rapidly detect individual virus particles cost-effectively, using a 3D-printed microscopy technology called Brick-MIC. This method boosts both sensitivity and specificity in virus detection, potentially transforming how viral outbreaks are monitored and managed. Its portable and user-friendly design makes it well-suited for wider clinical applications, strengthening public health responses to emerging viral challenges.

The breakthrough virus detection method developed by a group of researchers that included scientists from The Hebrew University of Jerusalem (Rehovot, Israel) uses laminar flow in a microfluidic channel along with fluorescence signals from free dyes and labeled antibodies to reveal key characteristics of nanoparticles. The team demonstrated the method's accuracy by testing it on fluorescent beads and various viruses, including the SARS-CoV-2 Spike protein. One of the key elements of this new assay is the use of hydrodynamic focusing, which significantly enhances sensitivity, enabling virus detection at clinically relevant concentrations.

Its portability and the use of the affordable 3D-printed Brick-MIC setup make it accessible for clinical environments. This innovation signals a shift toward rapid and precise virus detection, in line with personalized healthcare principles. By enabling fast, specific identification of viruses, this technology could help tailor medical interventions to individual patient needs, improving the timeliness and effectiveness of treatments. The research was published in iScience, with the 3D-printed microscopy approach detailed in Science Advances.

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Mumps Virus Test
ReQuest Mumps IgG
New
Treponema Pallidum Test
ZEUS IFA Fluorescent Treponemal Antibody-Absorption (FTA-ABS) Test System

Print article

Channels

Molecular Diagnostics

view channel
Image: The next-generation microfluidics-based CTC detection technology will improve early cancer screening (Photo courtesy of CityUHK)

Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring

Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Sekisui Diagnostics UK Ltd.